Upgrade to SI Premium - Free Trial

Madrigal Pharmaceuticals (MDGL) PT Raised to $565 at Goldman Sachs

March 18, 2024 6:10 AM
Goldman Sachs analyst Andrea Tan ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles